The pilot project, which is set to launch in February, will enable manufacturers of certain high-risk devices to receive advice on clinical development strategies from EU expert panels in the context of the Medical Device Regulation.
High-risk devices that fall into class III or are class IIb devices that are designed to administer or remove medicinal products from the body under the MDR risk classification system...